EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative…
EASL is now calling for applications for two new members to join its Governing Board as the Internal Affairs Councillor and the External Affairs Councillor. These key roles support the strategic direction and operational excellence of the Association—internally through member…
This paper is more than a review: it is a consensus report by a group of 34 leading international experts in hepatology, data science, and artificial intelligence, presenting concrete recommendations for the clinical application of AI in hepatology.
EASL joins the global hepatology community in mourning the passing of Professor Jaime Bosch, an exceptional clinician-scientist, educator and leader whose career has shaped the field of hepatology for over five decades. Born in Girona, Catalonia, on 10 August 1947,…
EASL has released its new Equity, Diversity, and Inclusion (EDI) Policy Statement and invites feedback. Built around the association’s four pillars: Education, Advocacy, Science, and Leadership, the statement reflects EASL’s commitment to creating an inclusive environment across all areas of…
EASL is proud to announce that both of its journals have achieved outstanding new impact factors, as released in the 2025 Journal Citation Reports (JCR) by ClarivateTM. The Journal of Hepatology, EASL’s flagship publication, has reached a record-high Impact Factor…
Barbora Smolkova, PhD, is a doctoral researcher at the Department of Paediatric Research at Oslo University Hospital, where she focuses on the cellular mechanisms of genetic liver diseases. Her work, which combines stem cell technologies and liver organoid models, recently…
EASL has published its Clinical Practice Guidelines on abdominal extrahepatic surgery in cirrhosis and advanced chronic liver disease. These guidelines represent a critical step forward in improving outcomes for a growing and vulnerable patient population. Addressing a complex clinical challenge…
EASL has released its newly updated Clinical Practice Guidelines (CPGs) on Autoimmune Hepatitis (AIH), bringing substantial revisions to the previous 2015 edition. Developed through a structured approach using PICO questions and a two-round Delphi panel process, the 2025 guidelines reflect…
EASL has released new Clinical Practice Guidelines (CPGs) for the management of extrahepatic cholangiocarcinoma (eCCA). These guidelines offer an updated, clinically oriented resource to support healthcare professionals in the accurate diagnosis and management of this malignancy. Developed using the PICO…